{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-298004","form_type":"8-K","ticker":"ALKS","cik":"0001520262","company_name":"Alkermes plc.","filed_at":"2026-07-08T12:00:15+00:00","discovered_at":"2026-07-08T12:05:00.259038+00:00","generated_at":"2026-07-08T12:05:19.304155+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Alkermes terminates authorized generic VIVITROL supply agreement with Amneal","bullets":["Agreement dated Sept 9, 2025, for Amneal to distribute authorized generic VIVITROL in the US.","Terminated July 6, 2026, after Amneal failed to meet certain terms and declined to order batches.","No penalties incurred; both parties released all claims related to the agreement.","No further payments or obligations owed by either party under the terminated agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-298004","json":"https://secwatch.observer/filing/0001193125-26-298004.json","markdown":"https://secwatch.observer/filing/0001193125-26-298004.md","text":"https://secwatch.observer/filing/0001193125-26-298004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1520262/000119312526298004/0001193125-26-298004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1520262/000119312526298004/alks-20260706.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-08T12:05:19.304155+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}